SCHEMBL8926809

SCHEMBL8926809

CC1C[C@H]2[C@@H]3CCN4C(C)C(=O)CC[C@]4(C)[C@@H]3CC[C@]2(C)C1OCC(=O)Nc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A1 P18405 4/20 0.37
SRD5A2 P31213 4/20 0.37
AR P10275 2/20 0.37
ALDH1A1 P00352 2/20 0.35
HTT P42858 1/20 0.35
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
NFKB1 P19838 1/20 0.32
MAPK1 P28482 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
HSD17B3 P37058 1/20 0.31
KCNH2 Q12809 1/20 0.31
HPGD P15428 1/20 0.31
CDC25A P30304 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8925157 0.85 SRD5A2 (0.32) SRD5A1SRD5A2ARNFKB1MAPK1
SCHEMBL8926431 0.85 AR (0.33) SRD5A2ARKCNH2
SCHEMBL8926954 0.80 SRD5A1 (0.36) SRD5A1SRD5A2ARALDH1A1HTT
SCHEMBL8926800 0.80 SRD5A1 (0.50) SRD5A1SRD5A2
SCHEMBL8925443 0.77 AR (0.34) SRD5A2ARALDH1A1MAPTMAPK1
SCHEMBL8726903 0.76 SRD5A1 (0.43) SRD5A1SRD5A2ARALDH1A1
SCHEMBL8726908 0.76 SRD5A1 (0.43) SRD5A1SRD5A2ARALDH1A1
SCHEMBL9113667 0.76 SRD5A1 (0.42) SRD5A1SRD5A2ARALDH1A1MAPT
SCHEMBL8927169 0.74 G6PD (0.36) SRD5A2ARKCNH2
SCHEMBL8926795 0.74 NR1H4 (0.36) SRD5A1SRD5A2ARHTTHSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5693809-A PREGNANES FOR TREATING ALOPECIA, ACNE AND SKIN DISORDER MERCK & CO., INC. (US) 1997-12-02 US disclosed